Loading market dashboard
Sabra Health Care REIT, Inc.
SBRAReal EstateNASDAQUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #NAREIT--In conjunction with upcoming investor meetings, Sabra Health Care REIT, Inc. (Nasdaq: SBRA) has issued a business update, which is available on the company's website. In addition, Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Darrin Smith, the company's Chief Investment Officer, and Lukas Hartwich, the company's Executive Vice President of Finance, will participate in Nareit's REITweek 2026 In.
Thirty-three US REITs utilized their at-the-market (ATM) offering programs during the recent quarter, raising $4.15 billion in aggregate proceeds. Healthcare REIT Welltower Inc. raised the most capital during the first quarter, selling nearly 7.7 million shares of common stock through its ATM program for $1.56 billion in gross proceeds. In the aggregate, healthcare REITs raised $2.67 billion through their ATM programs during the first quarter, the most of any property sector. The data center REIT sector was next with $875.0 million.
Investors with an interest in REIT and Equity Trust - Other stocks have likely encountered both FrontView REIT, Inc. (FVR) and Sabra Healthcare (SBRA). But which of these two stocks is more attractive to value investors?
Sabra Health Care REIT is rated a buy, reflecting portfolio growth, reasonable valuation, and robust geographic diversification. SBRA demonstrates strong revenue and NOI growth but faces declining EBITDA margins and flat long-term dividend growth, tempering its income appeal. The REIT maintains an investment-grade balance sheet, modest debt-to-equity, low operator concentration, and adequate AFFO dividend coverage with a 5.6% yield.
Sabra Health Care REIT is a 'Buy' with a near 6% yield and 13x forward P/FFO, supported by favorable demographics and industry supply constraints. SBRA's Q1 2026 normalized FFO grew 9% YoY, driven by 14.4% same-store SHOP NOI growth and robust occupancy gains. Management is aggressively deploying capital into SHOP-focused acquisitions at 8% initial cash yields, with a strong pipeline and mostly fixed operating expenses enabling positive operating leverage.
Global X SuperDividend REIT ETF (NYSEARCA:SRET) holds roughly 30 of the highest-yielding REITs worldwide, equally weighted, with monthly distributions.
U.S. equity markets advanced for a fifth straight week - their longest winning streak since 2024 - as strong earnings, resilient data, and hopes for lasting Iran peace fueled optimism. Investors looked through another oil-price surge and inflationary pressure, focusing instead on corporate resilience and economic strength despite a complex macro backdrop shaped by geopolitical and policy uncertainty. The Fed held rates steady in an unusually fractured 8-4 vote, while Powell's plan to remain on the Board broke precedent and raised politically charged succession questions.
Sabra Health Care REIT, Inc. (SBRA) Q1 2026 Earnings Call Transcript
Sabra Healthcare (SBRA) came out with quarterly funds from operations (FFO) of $0.39 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to FFO of $0.37 per share a year ago.
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #1Q26--Sabra Health Care REIT, Inc. (“Sabra,” the “Company” or “we”) (Nasdaq: SBRA) today announced its results of operations for the first quarter of 2026. FIRST QUARTER 2026 RESULTS AND RECENT EVENTS Results per diluted common share for the first quarter of 2026 were as follows: Net Income: $0.16 FFO: $0.37 Normalized FFO: $0.38 AFFO: $0.39 Normalized AFFO: $0.39 EBITDARM Coverage Summary: Skilled Nursing/Transitional Care: 2.46x Senior Housing - Leased: 1.58x Behavi.
Advisors Capital Management LLC raised its holdings in shares of Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) by 3.2% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,382,935 shares of the real estate investment trust's stock after purchasing an additional 73,281 shares during
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #SBRA--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Darrin Smith, the company's Chief Investment Officer, and Lukas Hartwich, the company's Executive Vice President of Finance, will attend Wells Fargo's 29th Annual Real Estate Securities Conference on May 4 – May 6, 2026, at The Charleston Place in Charleston, South Carolina. About Sab.
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #1Q26--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that it will issue its 2026 first quarter earnings release on April 29, 2026, after the close of trading. A conference call with a simultaneous webcast to discuss the 2026 first quarter results will be held on Thursday, April 30th at 10:00 a.m. Pacific Time. The dial-in number for U.S. participants is 888-880-4448. For participants outside the U.S., the dial-in number is 646-960-0572. The conference ID.
Healthcare real estate investment trusts (REITs), which own properties such as senior housing, medical office buildings, skilled nursing facilities, and hospitals, may present a compelling opportunity right now. The demographic tailwind is hard to ignore: the U.S. baby boomer generation is aging rapidly, driving sustained demand for senior living and medical facilities that is not... Our Favorite Passive Income Idea Pays Big Dividends and Grows Daily
Oil is up, and everything else is down. Stocks. Bonds.
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #SBRA--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Darrin Smith, the company's Chief Investment Officer, Eliza Gozar, the company's Senior Vice President of Investments, and other members of the company, will attend the 2026 NIC Spring Conference on March 30 – April 1, 2026, at the Omni Nashville Hotel in Nashville, Tennessee. About Sabra Sabra Health Care REIT, Inc., a Maryland corporat.
Cinctive Capital Management LP lifted its holdings in Sabra Healthcare REIT, Inc. (NASDAQ: SBRA) by 31.1% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 184,001 shares of the real estate investment trust's stock after purchasing an additional 43,669
Peakstone Realty Trust (NYSE: PKST - Get Free Report) and Sabra Healthcare REIT (NASDAQ: SBRA - Get Free Report) are both finance companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, earnings, valuation, profitability, dividends, institutional ownership and analyst recommendations. Analyst Recommendations This is a summary
Engineers Gate Manager LP sold 1,513,777 shares of Sabra Health Care REIT (SBRA) Quarter-end position value decreased by $26.85 million, reflecting both trading and price movement effects Transaction represented a 0.33% change in fund's 13F assets under management Post-trade, the fund holds 4,544,219 shares valued at $86.07 million The position now accounts for 1.02% of 13F AUM, placing it outside the fund's top five holdings
TUSTIN, Calif.--(BUSINESS WIRE)---- $SBRA #DBSummit--Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the company's Chair and Chief Executive Officer, Michael Costa, the company's Chief Financial Officer, Darrin Smith, the company's Chief Investment Officer, and Lukas Hartwich, the company's Executive Vice President of Finance, will participate in Deutsche Bank's 2026 Healthcare REIT Summit virtually on March 24, 2026. About Sabra Sabra Health Care REIT, Inc., a Maryland corporation, o.
Shares of Sabra Healthcare REIT, Inc. (NASDAQ: SBRA - Get Free Report) have earned an average recommendation of "Moderate Buy" from the ten ratings firms that are covering the stock, Marketbeat reports. Five analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month price
